Bill > SB95

This bill amends the Pharmacy Act to introduce several key provisions: First, it adds definitions for "EMS provider" (emergency medical services provider) and "dose package" related to naloxone distribution for opioid overdose reversal. Second, it establishes a new provisional licensing process for pharmacists from other states, allowing them to obtain a temporary 180-day license with simplified requirements. Third, the bill creates new regulations for EMS providers to distribute dose packages of naloxone to individuals who might assist someone experiencing an opioid overdose, with specific guidelines to protect the EMS provider. Fourth, the bill mandates price transparency in pharmacies, requiring pharmacists to disclose, upon request, the retail price of medications, the consumer's cost-sharing amount, and information about health insurance exchanges. Pharmacies must also display a notice informing consumers of their right to request such disclosures. The bill includes provisions for potential fines for non-compliance and requires the pharmacy board to develop regulations for implementation. The bill's effective dates vary, with some sections taking effect immediately, some in 60 days, and others in one year, reflecting the complexity and phased approach to implementing these pharmacy-related reforms.

Budget and Finance, Government Affairs, Military Affairs and Security

https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2025&sind=0&body=S&type=B&bn=95